NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Joel Raskin
Eli Lilly and Company - Indianapolis / United States
Social Sciences / Psychology
AD Scientific Index ID: 4398283
-
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Joel Raskin's MOST POPULAR ARTICLES
1-)
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic painJ Raskin, YL Pritchett, F Wang, DN D\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Souza, AL Waninger, S Iyengar, ...Pain Medicine 6 (5), 346-356, 20056782005
2-)
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic painJF Wernicke, YL Pritchett, DN D’souza, A Waninger, P Tran, S Iyengar, ...Neurology 67 (8), 1411-1420, 20066002006
3-)
On the path to 2025: understanding the Alzheimer’s disease continuumPS Aisen, J Cummings, CR Jack, JC Morris, R Sperling, L Frölich, ...Alzheimer\\\'s research & therapy 9, 1-10, 20174752017
4-)
Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trialJ Raskin, CG Wiltse, A Siegal, J Sheikh, J Xu, JJ Dinkel, BT Rotz, ...American Journal of Psychiatry 164 (6), 900-909, 20074752007
5-)
Drug development in Alzheimer’s disease: the path to 2025J Cummings, PS Aisen, B DuBois, L Frölich, CR Jack, RW Jones, ...Alzheimer\'s research & therapy 8, 1-12, 20164532016
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept